www.BuyersGuideChem.com - the directory of chemicals and chemical suppliers. The search engine opens a large data base and offers new supply sources
Sigma_aldrich Logo
Welcome About BGC Terms of Use MSDS Banner Adverts Statistics Impressum Sitemap
BGC > Product Search > Raltegravir potassium salt | 871038-72-1
english deutsch español

Suppliers for CAS

871038-72-1



 

Properties

CAS   871038-72-1 
Formula   C20H20FKN6O5 

Structure

14 Registered suppliers

Simagchem Corporation P.R.China
rd Raltegravir potassium salt  
Dayang Chem (Hangzhou) Co.,Ltd. P.R.China
rd Raltegravir potassium salt  
H&Z Industry Co.,Ltd P.R.China
rd Raltegravir potassium salt  
Hangzhou Meite Industry Co., Ltd (Hangzhou Meite Chemical Co., Ltd) P.R.China
rd Raltegravir potassium salt  
Leap Chem Co., Ltd P.R.China
rd Raltegravir potassium salt   CD details
rd Raltegravir-d3, potassium salt   CD details
Newstar Chem Enterprise Ltd. P.R.China
rd Raltegravir potassium salt  
Molecular Formula: C20H20FKN6O5
Molecular Weight: 482.5067032
Shandong Ench Chemical Co.,Ltd P.R.China
rd Raltegravir potassium salt  
Molecular Formula: C20H20FKN6O5
Molecular Weight: 482.5067032
Hangzhou Zhongqi Chem Co., Ltd P.R.China
rd Raltegravir potassium salt  
Molecular Formula: C20H20FKN6O5
Molecular Weight: 482.5067032
BOC Sciences USA
rd Raltegravir potassium salt   CD details
Shandong SanYoung Industry Co., Ltd P.R.China
rd Raltegravir potassium salt  
Description :
Raltegravir is a potent, selective, and orally bioavailable inhibitor of HIV integrase (IC50 = 15 nM). It is metabolized primarily by uridine diphosphate glucuronosyltransferase 1A. Raltegravir has long-term efficacy and safety in managing HIV-1 infection in adults, children, and adolescents.
  • Molecular Weight :482.514
  • Melting Point :155-157˚C (dec.)
  • Purity :98%
Molecular Formula :
C20H20FKN6O5
Canonical SMILES :
CC1=NN=C(O1)C(=O)NC(C)(C)C2=NC(=C(C(=O)N2C)[O-])C(=O)NCC3=CC=C(C=C3)F.[K+]
InChI :
InChI=1S/C20H21FN6O5.K/c1-10-25-26-17(32-10)16(30)24-20(2,3)19-23-13(14(28)18(31)27(19)4)15(29)22-9-11-5-7-12(21)8-6-11;/h5-8,28H,9H2,1-4H3,(H,22,29)(H,24,30);/q;+1/p-1
InChIKey :
IFUKBHBISRAZTF-UHFFFAOYSA-M
Solubility :
In Vitro: H2O: 25 mg/mL (51.81 mM; Need ultrasonic) DMSO : 6 mg/mL (12.43 mM; Need ultrasonic) In Vivo: 1.Add each solvent one by one: 10% DMSO > > 90% corn oil Solubility: ≥ 0.6 mg/mL (1.24 mM); Clear solution 2.Add each solvent one by one: 10% DMSO > > 40% PEG300 > > 5% Tween-80 > > 45% saline Solubility: ≥ 0.6 mg/mL (1.24 mM); Clear solution 3.Add each solvent one by one: 10% DMSO > > 90% (20% SBE-β-CD in saline) Solubility: ≥ 0.6 mg/mL (1.24 mM); Clear solution
Appearance :
White crystalline powder
Application :
Anti-HIV Agents
Storage : Powder: -20°C: 3 years 4°C: 2 years In solvent: -80°C: 6 months -20°C: 1 month
Synonyms :
MK-0518; MK 0518; MK0518; Raltegravir
More details are to be found here
Xiamen Equation Chemical Co.,Ltd P.R.China
rd Raltegravir potassium salt  
Description :
Raltegravir is a potent, selective, and orally bioavailable inhibitor of HIV integrase (IC50 = 15 nM). It is metabolized primarily by uridine diphosphate glucuronosyltransferase 1A. Raltegravir has long-term efficacy and safety in managing HIV-1 infection in adults, children, and adolescents.
  • Molecular Weight :482.514
  • Melting Point :155-157˚C (dec.)
  • Purity :98%
Molecular Formula :
C20H20FKN6O5
Canonical SMILES :
CC1=NN=C(O1)C(=O)NC(C)(C)C2=NC(=C(C(=O)N2C)[O-])C(=O)NCC3=CC=C(C=C3)F.[K+]
InChI :
InChI=1S/C20H21FN6O5.K/c1-10-25-26-17(32-10)16(30)24-20(2,3)19-23-13(14(28)18(31)27(19)4)15(29)22-9-11-5-7-12(21)8-6-11;/h5-8,28H,9H2,1-4H3,(H,22,29)(H,24,30);/q;+1/p-1
InChIKey :
IFUKBHBISRAZTF-UHFFFAOYSA-M
Solubility :
In Vitro: H2O: 25 mg/mL (51.81 mM; Need ultrasonic) DMSO : 6 mg/mL (12.43 mM; Need ultrasonic) In Vivo: 1.Add each solvent one by one: 10% DMSO > > 90% corn oil Solubility: ≥ 0.6 mg/mL (1.24 mM); Clear solution 2.Add each solvent one by one: 10% DMSO > > 40% PEG300 > > 5% Tween-80 > > 45% saline Solubility: ≥ 0.6 mg/mL (1.24 mM); Clear solution 3.Add each solvent one by one: 10% DMSO > > 90% (20% SBE-β-CD in saline) Solubility: ≥ 0.6 mg/mL (1.24 mM); Clear solution
Appearance :
White crystalline powder
Application :
Anti-HIV Agents
Storage : Powder: -20°C: 3 years 4°C: 2 years In solvent: -80°C: 6 months -20°C: 1 month
Synonyms :
MK-0518; MK 0518; MK0518; Raltegravir
More details are to be found here
Chemos GmbH & Co. KG Germany
rd Raltegravir potassium salt  
Description :
Raltegravir is a potent, selective, and orally bioavailable inhibitor of HIV integrase (IC50 = 15 nM). It is metabolized primarily by uridine diphosphate glucuronosyltransferase 1A. Raltegravir has long-term efficacy and safety in managing HIV-1 infection in adults, children, and adolescents.
  • Molecular Weight :482.514
  • Melting Point :155-157˚C (dec.)
  • Purity :98%
Molecular Formula :
C20H20FKN6O5
Canonical SMILES :
CC1=NN=C(O1)C(=O)NC(C)(C)C2=NC(=C(C(=O)N2C)[O-])C(=O)NCC3=CC=C(C=C3)F.[K+]
InChI :
InChI=1S/C20H21FN6O5.K/c1-10-25-26-17(32-10)16(30)24-20(2,3)19-23-13(14(28)18(31)27(19)4)15(29)22-9-11-5-7-12(21)8-6-11;/h5-8,28H,9H2,1-4H3,(H,22,29)(H,24,30);/q;+1/p-1
InChIKey :
IFUKBHBISRAZTF-UHFFFAOYSA-M
Solubility :
In Vitro: H2O: 25 mg/mL (51.81 mM; Need ultrasonic) DMSO : 6 mg/mL (12.43 mM; Need ultrasonic) In Vivo: 1.Add each solvent one by one: 10% DMSO > > 90% corn oil Solubility: ≥ 0.6 mg/mL (1.24 mM); Clear solution 2.Add each solvent one by one: 10% DMSO > > 40% PEG300 > > 5% Tween-80 > > 45% saline Solubility: ≥ 0.6 mg/mL (1.24 mM); Clear solution 3.Add each solvent one by one: 10% DMSO > > 90% (20% SBE-β-CD in saline) Solubility: ≥ 0.6 mg/mL (1.24 mM); Clear solution
Appearance :
White crystalline powder
Application :
Anti-HIV Agents
Storage : Powder: -20°C: 3 years 4°C: 2 years In solvent: -80°C: 6 months -20°C: 1 month
Synonyms :
MK-0518; MK 0518; MK0518; Raltegravir
More details are to be found here
BuGuCh & Partners Germany
rd Raltegravir potassium salt  
Description :
Raltegravir is a potent, selective, and orally bioavailable inhibitor of HIV integrase (IC50 = 15 nM). It is metabolized primarily by uridine diphosphate glucuronosyltransferase 1A. Raltegravir has long-term efficacy and safety in managing HIV-1 infection in adults, children, and adolescents.
  • Molecular Weight :482.514
  • Melting Point :155-157˚C (dec.)
  • Purity :98%
Molecular Formula :
C20H20FKN6O5
Canonical SMILES :
CC1=NN=C(O1)C(=O)NC(C)(C)C2=NC(=C(C(=O)N2C)[O-])C(=O)NCC3=CC=C(C=C3)F.[K+]
InChI :
InChI=1S/C20H21FN6O5.K/c1-10-25-26-17(32-10)16(30)24-20(2,3)19-23-13(14(28)18(31)27(19)4)15(29)22-9-11-5-7-12(21)8-6-11;/h5-8,28H,9H2,1-4H3,(H,22,29)(H,24,30);/q;+1/p-1
InChIKey :
IFUKBHBISRAZTF-UHFFFAOYSA-M
Solubility :
In Vitro: H2O: 25 mg/mL (51.81 mM; Need ultrasonic) DMSO : 6 mg/mL (12.43 mM; Need ultrasonic) In Vivo: 1.Add each solvent one by one: 10% DMSO > > 90% corn oil Solubility: ≥ 0.6 mg/mL (1.24 mM); Clear solution 2.Add each solvent one by one: 10% DMSO > > 40% PEG300 > > 5% Tween-80 > > 45% saline Solubility: ≥ 0.6 mg/mL (1.24 mM); Clear solution 3.Add each solvent one by one: 10% DMSO > > 90% (20% SBE-β-CD in saline) Solubility: ≥ 0.6 mg/mL (1.24 mM); Clear solution
Appearance :
White crystalline powder
Application :
Anti-HIV Agents
Storage : Powder: -20°C: 3 years 4°C: 2 years In solvent: -80°C: 6 months -20°C: 1 month
Synonyms :
MK-0518; MK 0518; MK0518; Raltegravir
More details are to be found here
Santa Cruz Biotechnology, Inc. USA
rd Raltegravir-d3, potassium salt  
Description :
Raltegravir is a potent, selective, and orally bioavailable inhibitor of HIV integrase (IC50 = 15 nM). It is metabolized primarily by uridine diphosphate glucuronosyltransferase 1A. Raltegravir has long-term efficacy and safety in managing HIV-1 infection in adults, children, and adolescents.
  • Molecular Weight :482.514
  • Melting Point :155-157˚C (dec.)
  • Purity :98%
Molecular Formula :
C20H20FKN6O5
Canonical SMILES :
CC1=NN=C(O1)C(=O)NC(C)(C)C2=NC(=C(C(=O)N2C)[O-])C(=O)NCC3=CC=C(C=C3)F.[K+]
InChI :
InChI=1S/C20H21FN6O5.K/c1-10-25-26-17(32-10)16(30)24-20(2,3)19-23-13(14(28)18(31)27(19)4)15(29)22-9-11-5-7-12(21)8-6-11;/h5-8,28H,9H2,1-4H3,(H,22,29)(H,24,30);/q;+1/p-1
InChIKey :
IFUKBHBISRAZTF-UHFFFAOYSA-M
Solubility :
In Vitro: H2O: 25 mg/mL (51.81 mM; Need ultrasonic) DMSO : 6 mg/mL (12.43 mM; Need ultrasonic) In Vivo: 1.Add each solvent one by one: 10% DMSO > > 90% corn oil Solubility: ≥ 0.6 mg/mL (1.24 mM); Clear solution 2.Add each solvent one by one: 10% DMSO > > 40% PEG300 > > 5% Tween-80 > > 45% saline Solubility: ≥ 0.6 mg/mL (1.24 mM); Clear solution 3.Add each solvent one by one: 10% DMSO > > 90% (20% SBE-β-CD in saline) Solubility: ≥ 0.6 mg/mL (1.24 mM); Clear solution
Appearance :
White crystalline powder
Application :
Anti-HIV Agents
Storage : Powder: -20°C: 3 years 4°C: 2 years In solvent: -80°C: 6 months -20°C: 1 month
Synonyms :
MK-0518; MK 0518; MK0518; Raltegravir
More details are to be found here
rd Raltegravir potassium salt  
Description :
Raltegravir is a potent, selective, and orally bioavailable inhibitor of HIV integrase (IC50 = 15 nM). It is metabolized primarily by uridine diphosphate glucuronosyltransferase 1A. Raltegravir has long-term efficacy and safety in managing HIV-1 infection in adults, children, and adolescents.
  • Molecular Weight :482.514
  • Melting Point :155-157˚C (dec.)
  • Purity :98%
Molecular Formula :
C20H20FKN6O5
Canonical SMILES :
CC1=NN=C(O1)C(=O)NC(C)(C)C2=NC(=C(C(=O)N2C)[O-])C(=O)NCC3=CC=C(C=C3)F.[K+]
InChI :
InChI=1S/C20H21FN6O5.K/c1-10-25-26-17(32-10)16(30)24-20(2,3)19-23-13(14(28)18(31)27(19)4)15(29)22-9-11-5-7-12(21)8-6-11;/h5-8,28H,9H2,1-4H3,(H,22,29)(H,24,30);/q;+1/p-1
InChIKey :
IFUKBHBISRAZTF-UHFFFAOYSA-M
Solubility :
In Vitro: H2O: 25 mg/mL (51.81 mM; Need ultrasonic) DMSO : 6 mg/mL (12.43 mM; Need ultrasonic) In Vivo: 1.Add each solvent one by one: 10% DMSO > > 90% corn oil Solubility: ≥ 0.6 mg/mL (1.24 mM); Clear solution 2.Add each solvent one by one: 10% DMSO > > 40% PEG300 > > 5% Tween-80 > > 45% saline Solubility: ≥ 0.6 mg/mL (1.24 mM); Clear solution 3.Add each solvent one by one: 10% DMSO > > 90% (20% SBE-β-CD in saline) Solubility: ≥ 0.6 mg/mL (1.24 mM); Clear solution
Appearance :
White crystalline powder
Application :
Anti-HIV Agents
Storage : Powder: -20°C: 3 years 4°C: 2 years In solvent: -80°C: 6 months -20°C: 1 month
Synonyms :
MK-0518; MK 0518; MK0518; Raltegravir
More details are to be found here
Detailed information on the suppliers of Raltegravir potassium salt

Properties:

... more properties and specification on Raltegravir potassium salt
© Copyright 1996 to 2024 by Netvertise GmbH. All rights reserved